Distribution of CD4+ T−cell response magnitude (BDPT-scaled) among 100 participants in all three trials with strong CD4+ T−cell responses.
figureposted on 30.01.2020, 18:40 by Lue Ping Zhao, Andrew Fiore-Gartland, Lindsay N. Carpp, Kristen W. Cohen, Nadine Rouphael, Llewellyn Fleurs, One Dintwe, Michael Zhao, Zoe Moodie, Youyi Fong, Nigel Garrett, Ying Huang, Craig Innes, Holly E. Janes, Erica Lazarus, Nelson L. Michael, Sorachai Nitayaphan, Punnee Pitisuttithum, Supachai Rerks-Ngarm, Merlin L. Robb, Stephen C. De Rosa, Lawrence Corey, Glenda E. Gray, Kelly E. Seaton, Nicole L. Yates, M. Juliana McElrath, Nicole Frahm, Georgia D. Tomaras, Peter B. Gilbert
The densities of the different CD4+ T-cell responses (color coded) and the average CD4+ T-cell response are shown by response level.
Read the peer-reviewed publication
RVpox-protein HIV vaccine regimenpox-protein HIV vaccine regimensbody mass indexIgGEnvelope glycoprotein 120 subunitMFadvance vaccine development objectives1Vcandidate vaccine multivariateSouth Africans Background HIV vaccine trialsHVTN 100multivariate binding antibodyT-cell response patternsbidirectional power transformationpox-protein HIV vaccinesAEALVAC-HIVNCT